Pfizer and Flagship Pioneering are ... potential lupus asset for Flagship’s Pioneering Medicines Valo Health now marks the sixth collaboration for the $7 billion biobucks, 10-program ...

Collaboration leverages Logica, a platform offering from Valo Health and Charles River that ... partnership between Flagship Pioneering and Pfizer to accelerate discovery of innovative compounds ...

Pfizer (PFE) and Pioneering Medicines, Flagship Pioneering’s in-house drug discovery and development unit, announced an agreement to discover ...

The collaboration between Pfizer and Pioneering Medicines ... an artificial intelligence (AI)-powered platform offering from Flagship-founded Valo Health, to identify advanceable small molecule leads.

In a statement on the Valo Health alliance, Novo Nordisk pointed to the potential for Opal to predict compound safety and efficacy and said that the collaboration may be extended to cover ...

Novo Nordisk has almost doubled the scale of an R&D alliance with Valo Health – a specialist in ... with Valo during the first year of our collaboration, and we are excited to expand the scope ...

Valo Health ... intelligence (AI), today announced a multi-year collaboration with nference, a company dedicated to transforming healthcare by making biomedical knowledge computable.

the result of a strategic collaboration between Charles River and Valo Health, is the industry’s first computation-powered, unified target-to-candidate offering. The platform leverages the ...

Denmark's Novo Nordisk on Wednesday announced an expansion of its collaboration with Valo Health to discover and develop novel treatments for obesity, type-2 diabetes, and cardiovascular disease.

The collaboration aims to provide a comprehensive biological characterization of the Pfizer compounds' potential beneficial effect on beta cell health and survival, building on unique beta cell ...